Allylated Curcumin Analog CA6 Inhibits TrxR1 and Leads to ROS-Dependent Apoptotic Cell Death in Gastric Cancer Through Akt-FoxO3a.
Vinothkumar RajamanickamTao YanLiangrong WuYanni ZhaoXiaohong XuHeping ZhuXi ChenMeihong WangZhoudi LiuZhiguo LiuGuang LiangYi WangPublished in: Cancer management and research (2020)
In summary, our studies demonstrate that CA6 inhibited gastric cancer growth by inhibiting TrxR1 and increasing ROS, which in turn activated FoxO3a through suppressing Akt. CA6 is a potential candidate for the treatment of gastric cancer.